These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1435910)

  • 1. Pharmaceutical promotions.
    Cassel CK
    N Engl J Med; 1992 Dec; 327(23):1687-8. PubMed ID: 1435910
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicians' interactions with pharmaceutical companies.
    Procopio L
    Pediatrics; 1992 Aug; 90(2 Pt 1):281-2. PubMed ID: 1641301
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicians, pharmaceutical representatives, and patients: who really benefits?
    Westfall JM
    J Fam Pract; 2000 Sep; 49(9):817-9. PubMed ID: 11032206
    [No Abstract]   [Full Text] [Related]  

  • 4. The regulatory morass: physicians' dealings with pharmaceutical manufacturers.
    Blehart B
    J Med Pract Manage; 2003; 19(3):164-5. PubMed ID: 14730825
    [No Abstract]   [Full Text] [Related]  

  • 5. Doctor, do you have a minute? The dilemma posed by physician interaction with the pharmaceutical industry.
    Quan SF
    J Clin Sleep Med; 2007 Jun; 3(4):345-6. PubMed ID: 17694720
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug industry and physicians--once more].
    Werkö L
    Lakartidningen; 1991 May; 88(22):2041-2. PubMed ID: 2051867
    [No Abstract]   [Full Text] [Related]  

  • 8. [Relations between physicians and the pharmaceutical industry].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1997; 49(1):79-80. PubMed ID: 9229760
    [No Abstract]   [Full Text] [Related]  

  • 9. The economic wisdom of regulating pharmaceutical "freebies".
    Fisher SH
    Duke Law J; 1991 Feb; (1):206-39. PubMed ID: 10114416
    [No Abstract]   [Full Text] [Related]  

  • 10. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between physicians and the pharmaceutical industry.
    Arkinstall WW
    CMAJ; 1995 Aug; 153(4):398-9. PubMed ID: 7634216
    [No Abstract]   [Full Text] [Related]  

  • 12. When physician-industry interactions go awry.
    Kassirer JP
    J Pediatr; 2006 Jul; 149(1 Suppl):S43-6. PubMed ID: 16829243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A tangled love affair.
    Fox ER
    West J Med; 1989 Apr; 150(4):484. PubMed ID: 2735060
    [No Abstract]   [Full Text] [Related]  

  • 14. Physicians and the pharmaceutical industry.
    Squires BP
    CMAJ; 1993 Nov; 149(10):1391-2. PubMed ID: 8221422
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
    Barton L
    J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
    Segal R; Grines LL; Pathak DS
    Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What drug rep visits cost you.
    Lowes R
    Med Econ; 2007 Aug; 84(15):49-51. PubMed ID: 17853853
    [No Abstract]   [Full Text] [Related]  

  • 19. Interacting with the pharmaceutical industry.
    Greenwald M
    CMAJ; 1994 Sep; 151(6):731; author reply 732. PubMed ID: 8087745
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the medical doctor in the pharmaceutical industry.
    Fitzgerald JD
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):447-54. PubMed ID: 4882610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.